fair prices ... s despite list prices that were within 1% of each other. Milliman suggests that clinical evidence may partly explain the differences in MFP between these drugs.

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

In addition to the record-breaking numbers of illnesses in Georgia, drugmakers raised the list prices on 575 name-brand drugs in the first two days of January 2025, according to drug price ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

Top doctors raised concerns about domestically made drugs ... driving down drug prices. But this year, foreign-branded drugs were largely absent from the government list of medicines that are ...

Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the quality of medicine. By Alexandra Stevenson and Zixu Wang Reporting from ...

The statement was the first by the new government since the outgoing administration earlier this month released a list of 15 drugs that are set to undergo the price negotiation process.

Drugmakers raised the list prices of more than 800 prescription drugs for blood pressure, cancer and other conditions by a median 4% at the start of this year. The modest size of the annual ...

The Centers for Medicare and Medicaid Services is moving forward with Medicare drug price negotiations under the Trump administration, although it said it is seeking to bring "greater transparency ...

Schumer added that Democrats will pressure President Trump to continue negotiations for lower Medicare drug prices ... top of the list is the high cost of prescription drugs,” Schumer ...

(Under Azar, Eli Lilly tripled the price of its top-selling insulin drug.) But Joe Biden’s Inflation Reduction Act did follow through. As a result, 10 popular drugs ... s list price in the ...